Mef2c regulates bone mass through Sost-dependent and -independent mechanisms.

Autor: Morfin C; School of Natural Sciences, University of California, Merced, CA, United States; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, United States., Sebastian A; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States., Wilson SP; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States., Amiri B; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States., Murugesh DK; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States., Hum NR; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States., Christiansen BA; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, United States., Loots GG; School of Natural Sciences, University of California, Merced, CA, United States; Physical and Life Sciences Directorate, Lawrence Livermore, National Laboratories, Livermore, CA, United States; Department of Orthopaedic Surgery, University of California Davis Health, Sacramento, CA, United States. Electronic address: gloots@ucdavis.edu.
Jazyk: angličtina
Zdroj: Bone [Bone] 2024 Feb; Vol. 179, pp. 116976. Date of Electronic Publication: 2023 Nov 30.
DOI: 10.1016/j.bone.2023.116976
Abstrakt: Mef2c is a transcription factor that mediates key cellular behaviors that promote endochondral ossification and bone formation. Previously, Mef2c has been shown to regulate Sost transcription via its osteocyte-specific enhancer, ECR5, and conditional deletions of Mef2c fl/fl with either Col1-Cre or Dmp1-Cre produced generalized high bone mass (HBM) consistent with Van Buchem Disease phenotypes. However, Sost -/- ; Mef2c fl/fl ; Dmp1-Cre mice produced a significantly higher bone mass phenotype that Sost -/- alone suggesting that Mef2c modulates bone mass through additional mechanisms, independent of Sost. To identify new Mef2c transcriptional targets important in bone metabolism, we profiled gene expression by single-cell RNA sequencing in subpopulations of cells isolated from Mef2c fl/fl ; Dmp1-Cre and Mef2c fl/fl ; Bglap-Cre femurs, both strains exhibiting similar high bone mass phenotypes. However, we found Mef2c fl/fl ; Bglap-Cre to also display a growth plate defect characterized by an expansion of several osteoprogenitor subpopulations. Differential gene expression analysis identified a total of 96 up- and 2434 down- regulated genes in Mef2c fl/fl ; Bglap-Cre and 176 up- and 1041 down- regulated genes in Mef2c fl/fl ; Dmp1-Cre bone cell subpopulations compared to wildtype mice. Mef2c deletion affected the transcriptomes across several cell types including mesenchymal progenitors (MP), osteoprogenitors (OSP), osteoblast (OB), and osteocyte (OCY) subpopulations. Several energy metabolism genes such as Uqcrb, Ndufv2, Ndufs3, Ndufa13, Ndufb9, Ndufb5, Cox6a1, Cox5a, Atp5o, Atp5g2, Atp5b, Atp5 were significantly down regulated in Mef2c-deficient OBs and OCYs, in both strains. Binding motif analysis of promoter regions of differentially expressed genes identified Mef2c binding in Bone Sialoprotein (BSP/Ibsp), a gene known to cause increased trabecular BV/TV in the femurs of Ibsp -/- mice. Immunohistochemical analysis confirmed the absence of Ibsp protein in OBs and OCYs. These findings suggests that the HBM in Sost -/- ; Mef2c fl/fl ; Dmp1-Cre is caused by a multitude of transcriptional changes in genes that regulate bone formation, two of which are Sost and Ibsp.
Competing Interests: Declaration of competing interest None. Authors have nothing to disclose.
(Copyright © 2023. Published by Elsevier Inc.)
Databáze: MEDLINE
Externí odkaz: